Navigation Links
PRA SPEAKING EVENT: Phase I Studies with Hepatitis C Compounds in Healthy Volunteers and Patients: Views from Inside
Date:4/8/2009

RALEIGH, N.C., April 8 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces Dr. Andre van Vliet, Vice President of Medical Affairs - Early Development Services (EDS), will host an audio conference on the development of New Chemical Entities (NCEs) in the treatment of hepatitis C. This interactive session will take place on April 14, 2009 at 11:30 am (ET). Drawing on his 19 years of experience in this field, Dr. van Vliet will provide an inside look at opportunities and obstacles when developing a hepatitis C compound including critical steps to optimize the success potential of an NCE as well as pitfalls and obstacles.

Dr. Andre van Vliet is a Board Certified internist, with expertise and training in oncology and clinical Pharmacology. His published materials include a recent article for the American Gastroenterological Association Institute on hepatitis C. Since 1995, he has supervised all aspects of Phase I and IIa drug research for PRA's EDS group.

With 228 beds in Europe and the U.S., and an innovative Phase I model that brings the center to the patients in Central/Eastern Europe, PRA's EDS group provides comprehensive services for Phase I and Phase IIa studies. In the Netherlands, PRA EDS initiated the "Dutch Hepatitis Research Initiative." In this unique research collaboration, PRA EDS collaborates with the Amsterdam Medical Centre and the Rotterdam Erasmus Medical Centre. In PRA's Product Registration group (Phase II and III), over a third of its project management and clinical operations employees are experienced in infectious diseases clinical research.

The deadline for registration is Monday, April 13, 2009. To learn more about the audio conference, click http://www.prainternational.com/portal/page/portal/PRAINTL/News%20%20Events/Events/Popup. To register, clickhttp://www.fxconferences.com/Phase-I-Studies-with-Hepatitis-C-Compounds-in-Healthy-Volunteers-and-Patients-Views-from-Inside-P317.aspx

About PRA International

PRA International is a global Clinical Research Organization providing services through all phases of clinical development. Although we specialize in Infectious Diseases, Oncology, CNS, Respiratory/Allergy and Cardiovascular, we perform studies in all therapeutic areas. PRA has supported over 2,100 clinical trials through its 35 global offices. PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge, enable our project teams to deliver consistent and on time performance for our clients.

To learn more about PRA International, please visit http://www.prainternational.com, email endpoints@praintl.com or call our Global Headquarters at +1 (919) 786-8200.


'/>"/>
SOURCE PRA International
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. PRA International Speaking Event: Beyond Global Feasibility
2. PRA International Speaking Event: Rational Drug Design and Development in Infectious Diseases
3. Folic acid survey of Spanish-speaking women finds most are missing benefits, March of Dimes says
4. First Nationwide Folic Acid Survey of Spanish-Speaking Women Finds Most Are Missing Benefits, March of Dimes Says
5. Newport Introduces More Resources for Spanish Speaking Plan Participants
6. Response rates to antidepressants differ among English- and Spanish-speaking Hispanics
7. When it comes to abstinence teens, adults arent speaking the same language
8. Children in non-English-speaking households face many health disparities, researcher concludes
9. Medpace Director of Clinical Pharmacology, Jim Wei, MD, PhD, Embarks on a Regulatory Policy Speaking Tour in China in May
10. Speaking of Womens Health Gives the Gift of Knowledge and Good Health This Mothers Day
11. Revolabs xTag(TM) Wireless Microphone Now Offered as a Total Solution With Dragon(R) NaturallySpeaking(R) Medical Software from Nuance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Opelousas, LA (PRWEB) , ... February 12, 2016 , ... ... of St. Landry and Evangeline Parishes. The purpose of these scholarships is to ... to encourage those individuals to seek employment within these two parishes. , “We ...
(Date:2/12/2016)... Boca Raton, FL (PRWEB) , ... February 12, ... ... nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving ... patient services – hosted over 250 members of South Florida’s philanthropic community at ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... 29, 2016 — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... the life cycle of pharmaceutical products, garnering increased attention from all stakeholders in ...
(Date:2/12/2016)... ... 2016 , ... As a former television executive, owner Tal Rabinowitz knows how ... to decompress, Rabinowitz found herself drawn to a casual meditation class while working at ... life, implementing a 20-minute-per-day meditation practice with her team. After her tenure at NBC, ...
(Date:2/12/2016)... ... February 12, 2016 , ... T.E.N., a technology and ... the ISE Southeast Awards 2016. Finalists and winners of the ISE® Awards for ... Forum and Awards Gala on March 15, 2016 at the Westin Peachtree Plaza, ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... -- The primary goal of this research is to ... usage of liquid biopsy. Key information the survey seeks ... of liquid biopsy adoption amidst future users - Predominantly ... - Sample inflow to conduct liquid biopsy tests - ... so on. - Correlation analysis of sample type and ...
(Date:2/11/2016)... Calif. , Feb. 11, 2016  Walgreens has ... across 39 states and Washington, D.C. ... a move that was commended by shareholder advocacy organization As ... at As You Sow. "Many people hold on to unneeded ... which can have tragic consequences." --> Conrad ...
(Date:2/11/2016)... -- MiMedx Group, Inc. (NASDAQ: MDXG ), the leading ... birth tissues, human skin and bone, and patent-protected processes ... and therapies, announced today that it will present at ... New York , NY.  Parker H. ... , Chief Financial Officer and Chris Cashman , ...
Breaking Medicine Technology: